Franklin Resources’s Iterum Therapeutics ITRM Stock Holding History

Franklin Resources’s Portfolio ITRM Stock Details ITRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-17,427	Closed	-$14.6K	–	2355
2022 Q4	$14.6K	Hold	17,427	–	–	﹤0.01%	2289
2022 Q3	$28K	Buy	17,427 +175	+1%	+$531	﹤0.01%	2241
2022 Q2	$52K	Sell	17,252 -8,361	-33%	-$31.3K	﹤0.01%	2240
2022 Q1	$136K	Hold	25,613	–	–	﹤0.01%	2239
2021 Q4	$151K	Hold	25,613	–	–	﹤0.01%	2282
2021 Q3	$215K	Buy	+25,613	New	+$316K	﹤0.01%	2211
2019 Q4	–	Sell	-16,386	Closed	-$1.45M	–	1558
2019 Q3	$1.45M	Sell	16,386 -7,051	-30%	-$686K	﹤0.01%	1219
2019 Q2	$2.42M	Sell	23,437 -397	-2%	-$44.1K	﹤0.01%	1138
2019 Q1	$2.87M	Hold	23,834	–	–	﹤0.01%	1087
2018 Q4	$1.79M	Hold	23,834	–	–	﹤0.01%	1152
2018 Q3	$2.4M	Sell	23,834 -1,807	-7%	-$236K	﹤0.01%	1183
2018 Q2	$4.19M	Buy	+25,641	New	+$4.63M	﹤0.01%	1068

Other funds holding ITRM

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Krilogy Financial St. Louis, Missouri $3.38B AUM 30.57% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

FWM

Focused Wealth Management Newburgh, New York $1.15B AUM 24.81% 1-Year Est. Return

Northwestern Mutual Wealth Management Milwaukee, Wisconsin $187B AUM 21.7% 1-Year Est. Return

KFS

Kelly Financial Services Braintree, Massachusetts $467M AUM 21.13% 1-Year Est. Return

NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Franklin Resources's ITRM Position: Q1 2023 in Review

Franklin Resources sold out of Iterum Therapeutics (ITRM) in Q1 2023, closing a stake of 17,427 shares — an estimated $14.6K sold.

Franklin Resources first reported a position in ITRM in Q2 2018 and held it in 12 quarters. The position peaked at $4.19M in Q2 2018. 17 funds tracked by Wall St. Rank hold ITRM as of Q1 2023.

Franklin Resources reported no remaining Iterum Therapeutics position as of Q1 2023 after selling out during the quarter.
Franklin Resources sold 17,427 Iterum Therapeutics shares in Q1 2023, an estimated $14.6K.
Franklin Resources first reported a position in Iterum Therapeutics in Q2 2018 and held it in 12 quarters.
Franklin Resources's Iterum Therapeutics position peaked at $4.19M in Q2 2018.
17 funds tracked by Wall St. Rank held Iterum Therapeutics as of Q1 2023.

Based on Franklin Resources's 13F filing for Q1 2023, filed 12 May 2023.